Blue Cap AG Announces Management Board Transition

Blue Cap AG, a Munich-based publicly traded investment company, has announced a significant change to its Management Board. Dr Henning von Kottwitz, Chairman of the Management Board, will depart the company effective 8 October 2026, following a mutual agreement with the Supervisory Board. The Supervisory Board expressed its gratitude for his service and credited him with positioning Blue Cap AG well for future development, particularly through transactions implemented in recent years. In a swift transition, the Supervisory Board has resolved to second its Chairman, Dr Christian Diekmann, to the Management Board as a member starting 9 October 2026, in accordance with Section 105(2) of the German Stock Corporation Act. Dr Diekmann will oversee strategy and finance. Henning Eschweiler will remain COO, responsible for operational portfolio management, and will additionally assume responsibility for M&A from the same date.

Dr Christian Diekmann brings a wealth of experience, having served as Chairman of Blue Cap AG’s Supervisory Board since 2024 and previously as CEO of Max Automation SE and CFO of Zertus Group. Dr Michael Schieble, Deputy Chairman of the Supervisory Board, praised Dr Diekmann’s deep understanding of Blue Cap and its potential as a listed investment company executing the Buy-Transform-Sell strategy. Dr Diekmann himself emphasized Blue Cap’s positioning as an investor in ‘special situations’ and its aim to strengthen Germany as an industrial location while creating shareholder value. Blue Cap AG, founded in 2006, acquires medium-sized B2B companies in the DACH region with revenues between EUR 20 million and EUR 200 million, currently holding majority stakes in six portfolio companies across plastics engineering, production engineering, pre-press solutions, life sciences, and business services. The Group employs around 2,000 people globally. For more information, visit www.blue-cap.de.